Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

NCT00447460 is registered in ClinicalTrials.gov with University of Salamanca as lead sponsor.

NCT NCT00447460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00447460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell
Lead sponsor
University of Salamanca
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2007
Completion date
August 31, 2009
Enrollment
15
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

graft-vs-host disease (gvhd)